このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

ECS Botanics Holdings バランスシートの健全性

財務の健全性基準チェック /66

ECS Botanics Holdingsの総株主資本はA$23.5M 、総負債はA$0.0で、負債比率は0%となります。総資産と総負債はそれぞれA$30.5MとA$7.0Mです。 ECS Botanics Holdingsの EBIT はA$2.5Mで、利息カバレッジ比率106.5です。現金および短期投資はA$4.3Mです。

主要情報

負債資本比率

AU$0

負債

インタレスト・カバレッジ・レシオ	106.5x
現金	AU$4.32m
エクイティ	AU$23.53m
負債合計	AU$6.96m
総資産	AU$30.49m

財務の健全性に関する最新情報

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Feb 24

Recent updates

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

Apr 03

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Sep 06

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Feb 24

財務状況分析

短期負債: ECSの短期資産 ( A$18.3M ) が短期負債 ( A$6.3M ) を超えています。

長期負債: ECSの短期資産 ( A$18.3M ) が長期負債 ( A$648.3K ) を上回っています。

デット・ツー・エクイティの歴史と分析

負債レベル: ECSは負債がありません。

負債の削減: ECS 5 年前には負債がありませんでした。

債務返済能力: ECSには負債がないため、営業キャッシュフローでカバーする必要はありません。

インタレストカバレッジ: ECSには負債がないため、利息支払いの負担は問題になりません。

ECS Botanics Holdings バランスシートの健全性

財務の健全性 基準チェック /66

主要情報

財務の健全性に関する最新情報

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Recent updates

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

New minor risk - Profit margin trend

New minor risk - Shareholder dilution

First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.001 loss in 1H 2023)

ECS Botanics Holdings Ltd to Report Q2, 2024 Results on Feb 28, 2024

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.000016 million.

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Full year 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2022)

New minor risk - Financial data availability

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2023

ECS Botanics Holdings Ltd Launches Investor Hub

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022)

ECS Botanics Holdings Ltd Announces Resignation of Mr. Alex Keach as Head of Corporate Development and an Executive Director

No independent directors

Blue Buffalo Pty Ltd has entered into a binding share purchase agreement to acquire ECS Botanics Pty Ltd from ECS Botanics Holdings Ltd (ASX:ECS) for AUD 3 million.

Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in FY 2021)

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2022

MD & Executive Director recently bought AU$90k worth of stock

ECS Botanics Holdings Ltd Announces Change of Managing Director

ECS Botanics Holdings Ltd Announces Executive Changes

No independent directors

Founder exercised options to buy AU$510k worth of stock.

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

ECS Botanics Holdings Ltd Launches Innovative range of 30ml Terpene Blends

ECS Botanics Holdings Ltd Appoints Nan Maree Schoerie as Director

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)

ECS Botanics Holdings Ltd Appoints Paul Hanrahan as Site & Cultivation Manager

ECS Botanics Holdings Ltd (ASX:ECS) signed a binding term sheet to acquire Murray Meds Pty Ltd, Flowerday Farms Pty Ltd and Flowerday Land Property from Flowerday Holdings Pty Ltd for AUD 7.5 million.

ECS Botanics Holdings Ltd Enters into Term Sheet with Medipharm Labs

ECS Botanics Holdings Ltd announced that it expects to receive AUD 4 million in funding

ECS Provides Medicinal Cannabis Project and Regulatory Update

ECS Botanics Holdings Ltd Appoints Damian Wood as Director of Medicinal Cannabis Production

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.75 million.

財務状況分析

デット・ツー・エクイティの歴史と分析

貸借対照表

健全な企業の発掘

財務の健全性基準チェック /66